Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS North America Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certifications and Educational Credits
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Preview AMS TV
Features
AMS Features
News & Publications
AMS Bookstore
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Psoriasis and risk of the COVID-19: is there a role for angiotensin converting enzyme (ACE)?
By
- AMS
posted
Jun 30, 2020 02:38 PM
0
Recommend
.
0 comments
0 views
Permalink
Related Content
MINERVA RESEARCH LABS ON COVID 19 TESTS
- AMS
Added Apr 30, 2020
Blog Entry
Delay Surgery By 7 Weeks After Covid Diagnosis: Study
- AMS
Added Apr 21, 2021
Blog Entry
Use of systemic therapies for psoriasis in the COVID-19 era
- AMS
Added Jan 28, 2021
Blog Entry
Psoriasis and COVID-19: a multifactorial consideration
- AMS
Added Jun 22, 2020
Blog Entry
Is biologic treatment of hidradenitis suppurativa during the COVID-19 pandemic different from psoriasis biologic treatment?
- AMS
Added Jun 19, 2020
Blog Entry
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic